What is the primary purpose of this 10-Q filing for Boston Scientific?

This 10-Q filing provides a quarterly update on Boston Scientific Corporation's financial performance and operational activities for the period ending September 29, 1996. It is a crucial document for investors to assess the company's financial health, profitability, and business developments.

What specific financial information can investors expect to find in this report?

While the provided text is a directory listing, a full 10-Q filing typically includes detailed financial statements such as the balance sheet, income statement, and cash flow statement, along with management's discussion and analysis (MD&A) of the financial condition and results of operations.

What industry does Boston Scientific operate in, and why is that important for investors?

Boston Scientific operates in the medical device industry. This sector is important for investors because it is characterized by rapid technological advancements, significant research and development investment, a complex regulatory environment, and a direct impact on healthcare outcomes, all of which can influence the company's financial performance and growth potential.

Where can I find the actual financial data and details from this 10-Q report?

The provided text is a directory listing from the SEC EDGAR database. To access the detailed financial statements and the full content of the 10-Q filing, you would typically need to click on the .txt or HTML file links within the EDGAR database for filing number 000091064796000194.

BSX 10-Q Quarterly Report Q3 FY1996 — Revenue, Net Income, EPS

Summary

Boston Scientific Corporation (BSX) filed its 10-Q report for the period ending September 29, 1996. This filing provides a snapshot of the company's financial performance and operational status during the third quarter of fiscal year 1996. As a company focused on the medical device industry, investors would be keen to understand its revenue generation, profitability, and any significant developments that could impact future growth. The report details the company's financial position and the results of its operations, offering insights into its competitive landscape and strategic direction within the dynamic healthcare sector. While specific financial figures and operational details are not fully provided in the extracted text, this 10-Q serves as a crucial disclosure for investors to assess Boston Scientific's standing. It is essential for evaluating the company's ability to generate value, manage its expenses, and invest in research and development or strategic acquisitions. Investors should review the full filing to gain a comprehensive understanding of the company's financial health and future prospects.

Key Highlights

1The 10-Q filing covers the third quarter of fiscal year 1996 for Boston Scientific Corporation (BSX).
2The report provides essential financial and operational data for investors to assess the company's performance during the period.
3Boston Scientific operates within the medical device industry, a sector characterized by innovation and regulatory oversight.
4This filing is a key disclosure document for understanding the company's financial position and results of operations.
5Investors can use this report to gauge the company's revenue, profitability, and growth trajectory.
6The filing would detail any significant events, risks, or management's discussion and analysis pertinent to the quarter.

BOSTON SCIENTIFIC CORP Quarterly Report for Q3 Ended Sep 30, 1996

Summary

Key Highlights

Frequently Asked Questions